v3.26.1
Note 9 - Segment Information
 6 Months Ended
Jun. 30, 2026
Notes to Financial Statements  
Segment Reporting [Text Block]

Note 9 – Segment Information

 

We manage our business activities on a consolidated basis and operate as a single operating segment dedicated to developing and marketing products for chronic wound care that harness the regenerative capacity of the human body to trigger natural healing. We derive our revenue from product sales of the Aurix product line. The accounting policies of the segment are the same as those described in Note 2 – Liquidity and Summary of Significant Accounting Policies.

 

Our CODM is Nuo's Chief Executive and Financial Officer, David E. Jorden. The CODM uses net loss, as reported in our consolidated statements of operations, in evaluating the performance of the segment and determining how to allocate our resources as a whole. The CODM does not review assets in evaluating the results of the segment, and therefore, such information is not presented.

 

The following table presents the operating results of the segment:

 

   

Three Months

Ended June 30,

    

Three Months

Ended June 30,

    

Six Months

Ended June 30,

    

Six Months

Ended June 30,

  
   

2026

    

2025

    

2026

    

2025

  

Total revenues

   $ 1,768,986     $ 700,202     $ 3,071,101     $ 1,184,583  

Less significant segment expenses:

                                

Aurix cost of sales (excluding provision for inventory obsolescence and applicable depreciation expense)

     321,897       140,807       574,508       241,499  

Private label cost of sales

     257,042       -       438,275       -  

Total compensation and benefit costs (including third party commission expense)

     823,373       645,902       1,654,143       1,208,809  

Provisions for credit losses and inventory obsolescence

     -       -       -       21,644  

All other operating expenses (excluding depreciation and credit loss provision) (a)

     446,136       501,604       865,378       993,948  

Other segment items:

                                

Depreciation, amortization of right of use assets, and stock-based compensation

     87,090       63,911       151,815       115,852  

Interest expense (income), net

     114,066       (1,153 )     289,348       442  

Other expense (income), net

     (3,017 )     (1,180 )     (6,299 )     (1,794 )

Consolidated net loss

   $ (277,601 )   $ (649,689 )   $ (896,067 )   $ (1,395,817 )

 

(a) All other operating expenses included in consolidated net loss includes professional fees, lease expenses, insurance costs, travel and entertainment expenses, and all other selling, general and administrative expenses.